Role of ING4 in human melanoma cell migration, invasion and patient survival

Jun Li1, Magdalena Martinka, Gang Li

  • 1Department of Dermatology and Skin Science, Jack Bell Research Centre, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia V6H 3Z6, Canada.

Carcinogenesis
|April 1, 2008
PubMed

Insights

Inhibitor of growth 4 (ING4) is decreased in melanoma, correlating with thicker tumors and poorer survival. Overexpressing ING4 suppresses melanoma cell migration, invasion, and metastasis, suggesting it

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Inhibitor of growth 4 (ING4) is a known tumor suppressor involved in apoptosis and cell cycle arrest.
  • Its role in human melanoma pathogenesis requires further investigation.

Purpose of the Study:

  • To investigate the role of ING4 in human melanoma.
  • To evaluate ING4 as a prognostic marker and potential therapeutic target.

Main Methods:

  • Tissue microarray analysis of ING4 expression in melanoma and dysplastic nevi.
  • Correlation analysis of ING4 expression with clinical parameters and patient survival.
  • In vitro studies assessing the effects of ING4 overexpression on melanoma cell migration, invasion, and matrix metalloproteinase activity.

Main Results:

  • ING4 expression is significantly decreased in malignant melanoma compared to dysplastic nevi.
  • Reduced ING4 expression correlates with increased melanoma thickness, ulceration, and poorer patient survival.
  • Overexpression of ING4 inhibits melanoma cell migration (63%), invasion (43%), and reduces the activity of MMP-2 and MMP-9.

Conclusions:

  • ING4 downregulation is associated with melanoma progression and poor prognosis.
  • ING4 acts as a suppressor of melanoma cell migration and invasion.
  • ING4 represents a potential prognostic biomarker and therapeutic target for melanoma.